# Argonaut Manufacturing Services

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/argonaut-manufacturing-services

- Industry: Biotechnology
- Headquarters: Carlsbad, US
- Website: www.argonautms.com
- Total disclosed funding: $35M
- Latest round: Series A (Mar 5, 2024)
- Investors on record: 2

## About

Founded in 2016 and based in California, US, Argonaut Manufacturing Services, Inc. operates as a drug product manufacturing firm that manufactures various drug products like plasmids, peptides, and oligos (ASO, mRNA, siRNA, gRNA, etc.). The company was founded by its CEO, Wayne Woodard. In March 2024, Argonaut Manufacturing Services, Inc. raised USD 45 million in venture funding led by NewVale Capital and Telegraph Hill Partners.

Argonaut Manufacturing Services manufactures biopharmaceutical, pharmaceutical, life science, and in-vitro diagnostic (IVD) products. The services offered by the company include drug product manufacturing, life sciences and IVD manufacturing, combination product manufacturing, lyophilization, analytical services, aseptic fill and finish, and many more.

The company plans to use the funds raised in March 2024 to assist in its expansion of new drug product fill and finish capabilities.

## Funding rounds

- Series A, Mar 5, 2024, $35M — Telegraph Hill Partners, NewVale Capital

## Investors

- Telegraph Hill Partners (https://capitalatlas.ai/funds/telegraph-hill-partners) — Series A
- NewVale Capital (https://capitalatlas.ai/funds/newvale-capital) — Series A